HealthcareServices

Sclerotherapy Market Outlook 2026–2035: Growth Drivers and Industry Forecast

March 2, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the sclerotherapy market from 2026–2035 with trusted insights from The Business Research Company

How much larger will the Sclerotherapy Market be in 2030 compared with 2026?

The sclerotherapy market size has seen significant growth in recent years. It is anticipated to expand from $1.21 billion in 2025 to $1.29 billion in 2026, achieving a compound annual growth rate (CAGR) of 6.4%. Several factors contributed to this historic growth, including limited awareness of treatments, the prevalence of conventional sclerosing agents, a low adoption rate of cosmetic procedures, existing regulatory limitations, and high treatment costs.

The sclerotherapy market size is projected to experience substantial expansion over the next few years. It is forecast to reach $1.65 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 6.2%. This growth during the forecast period is primarily driven by the introduction of safer sclerosants, advancements in delivery techniques, the proliferation of aesthetic clinics, the expansion of medical tourism, and improvements in insurance coverage. Noteworthy trends for the forecast period include the increasing adoption of minimally invasive procedures, the development of advanced foam sclerosants, the application of combination therapies, an upsurge in outpatient treatments, and the continued rise in medical tourism.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24394&type=smp

What Drivers Are Guiding Growth Patterns In The Sclerotherapy Market?

The increasing occurrence of varicose and spider veins is anticipated to fuel the expansion of the sclerotherapy market in the coming years. These conditions involve veins that become enlarged, twisted, or damaged, commonly seen under the skin and resulting from inadequate blood flow, particularly in the legs. The increase in these vein issues is largely attributed to individuals spending extended periods in sedentary or upright positions, often associated with contemporary professional practices. Sclerotherapy provides a solution for these prevalent vein problems through the precise injection of a specialized solution that effectively seals off the compromised veins, thereby enhancing blood circulation and visual appearance. For instance, in January 2024, data from the National Center for Biotechnology Information, a US-Based health information organization, indicated that in Brazil, 47.6% of the population suffered from varicose veins (VVs), with non-pregnant women exhibiting a higher incidence at 50.9% compared to 37.9% in men. Consequently, the growing incidence of varicose and spider veins is set to propel the growth of the sclerotherapy market.

Sclerotherapy Market Driver: Increasing Healthcare Expenditure Driving Market Growth Through Enhanced Access To Advanced Treatments

The upward trend in healthcare spending is projected to stimulate the expansion of the sclerotherapy market in the foreseeable future. Healthcare expenditure encompasses all financial outlay on medical services, therapies, and health-related assets within a national system. The primary impetus behind rising healthcare costs is the escalating expense of sophisticated medical technologies, which, despite advancing diagnostic and treatment capabilities, demand substantial investment in their creation, equipment, and specialized personnel. This expenditure supports sclerotherapy by ensuring funding for access to specialized treatments, medical professionals, and advanced machinery. For instance, in May 2024, the Office for National Statistics, a UK-based government department, reported that in 2024, the UK’s healthcare expenditure reached approximately $421.32 billion (£317 billion), marking a 6.5% increase compared to 2023. Therefore, the increase in healthcare expenditure is poised to drive the growth of the sclerotherapy market.

Which Segments Are Driving Activity In The Sclerotherapy Market?

The sclerotherapy market covered in this report is segmented –

1) By Type: Liquid Sclerotherapy, Foam Sclerotherapy, Ultrasound-Guided Sclerotherapy

2) By Agents: Detergents, Chemical Irritants, Osmotic Agents

3) By Application: Varicose Veins, Spider Veins, Hemorrhoids

4) By End-User: Hospitals, Ambulatory Surgical Centers, Specialty Clinics, Other End-Users

Subsegments:

1) By Liquid Sclerotherapy: Polidocanol-based, Sodium Tetradecyl Sulfate (STS)-based, Hypertonic Saline-based

2) By Foam Sclerotherapy: Polidocanol Foam, STS Foam, Air-based Foam

3) By Ultrasound-Guided Sclerotherapy: Foam-guided, Liquid-guided, Combination Therapies

Which Trends Are Expected To Influence The Sclerotherapy Market In The Upcoming Years?

Leading companies within the sclerotherapy market are concentrating on strategic alliances to boost their research capabilities, broaden their product offerings, and strengthen their market presence through shared expertise and global distribution networks. Modern, minimally invasive therapies for varicose veins encompass contemporary procedures like sclerotherapy, laser therapy, and radiofrequency ablation, which effectively close or remove damaged veins with minimal discomfort, swift recovery, and a reduced risk of complications. For instance, in February 2025, Aakash Healthcare, an India-Based specialty hospital, partnered with Medtronic plc, a US-based healthcare company, to launch a specialized vein clinic. This clinic provides advanced, minimally invasive treatments for varicose veins and other vein-related conditions, ensuring faster recovery and long-term health benefits for patients. Additionally, it offers enhanced personalized treatment plans and post-treatment care, ensuring a comprehensive approach to vein health and overall well-being.

Which Key Market Players Are Investing In Expansion And Innovation Within The Sclerotherapy Market?

Major companies operating in the sclerotherapy market are Bayer AG, Sanofi S.A., Abbott Laboratories, Novartis AG, Medtronic plc, Boston Scientific Corporation, Olympus Corporation, Smith And Nephew plc, Teleflex Incorporated, Cook Medical, Merz Pharma GmbH And Co KGaA, AngioDynamics Inc, Bioniche Pharma Group Ltd, Omega Pharmaceuticals Pvt Ltd, Endo Flex, Kreussler, Vascular Solutions Inc, BTG International Ltd, Boston Biomedical Inc, Cardinal Health Inc, Terumo Corporation, B Braun Melsungen AG, BD Bard, MedAlliance SA

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/sclerotherapy-global-market-report

Which Regions Are Poised For Strategic Growth In The Sclerotherapy Market?

North America was the largest region in the sclerotherapy market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the sclerotherapy market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Sclerotherapy Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=24394&type=smp

Browse Through More Reports Similar to the Global Sclerotherapy Market 2026, By The Business Research Company

Pressotherapy Systems Market Report 2026

https://www.thebusinessresearchcompany.com/report/pressotherapy-systems-global-market-report

Cryotherapy Market Report 2026

https://www.thebusinessresearchcompany.com/report/cryotherapy-global-market-report

Sphygmomanometer Market Report 2026

https://www.thebusinessresearchcompany.com/report/sphygmomanometer-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795